8. Pendrell Corporation (PCO): Through its wholly-owned subsidiary, Pendrell Technologies, Inc., provides corporate intellectual property solutions and litigation insights to Fortune 500 companies and technology firms worldwide. Market cap at $304.9M, most recent closing price at $1.17. Net institutional purchases in the current quarter at 36.2M shares, which represents about 25.41% of the company’s float of 142.45M shares. Over the last six months, insiders were net buyers of 2,500,000 shares, which represents about 1.76% of the company’s 142.45M share float.
9. Repros Therapeutics Inc. (RPRX): Market cap at $239.68M, most recent closing price at $14.0. Net institutional purchases in the current quarter at 2.6M shares, which represents about 20.44% of the company’s float of 12.72M shares. Over the last six months, insiders were net buyers of 557,500 shares, which represents about 4.38% of the company’s 12.72M share float.
10. Tenet Healthcare Corp. (THC): Operates acute care hospitals and related health care facilities. Market cap at $3.21B, most recent closing price at $30.15. Net institutional purchases in the current quarter at 10.3M shares, which represents about 11.44% of the company’s float of 90.02M shares. Over the last six months, insiders were net buyers of 3,000,000 shares, which represents about 3.33% of the company’s 90.02M share float. 11. Uranium Resources, Inc. (URRE): Engages in the acquisition, exploration, development, and mining of uranium properties, using the in situ recovery or solution mining process. Market cap at $53.14M, most recent closing price at $0.33. Net institutional purchases in the current quarter at 34.0M shares, which represents about 29.66% of the company’s float of 114.65M shares. Over the last six months, insiders were net buyers of 34,330,500 shares, which represents about 29.94% of the company’s 114.65M share float. Compare 1 year returns and analyst ratings for the stocks listed above:Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
